ARCHIVES

XGEVA not Inferior to Zometa In 1,776-Patient Phase III Study

This article is from The Cancer Letter archive.

Vol. 34 No. 3 | March 25, 2011

Download PDF Visit The Full Archive

Related Articles

Rauscher Mammography Guidelines Would Limit Annual Use To Members Of High Risk Group

August 13, 1976

Working Group to Look At Guidelines, Mandates, Centers Role In Prevention, Cancer Control

February 17, 1984

HHS Inquiry Triggers Sloppy Stories On Gallo’s Laboratory

July 21, 1989

FCRC Decision Due In 90 Days, Upton Says

November 24, 1978

NCI Seeks Changes In CIS Funding Plan With Next Recompetition

April 24, 1987

Ganz Awarded Professor Of Survivorship By Komen.

January 28, 2000